Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
暂无分享,去创建一个
M. Naghavi | Dillon O Sylte | Farah Daoud | W. La Motte-Kerr | Parkes J. Kendrick | L. Dwyer-Lindgren | E. J. Rodriquez | Lisa M. Force | Mathew M. Baumann | E. Pérez-Stable | H. Nassereldine | K. Compton | A. Nápoles | Chris Schmidt | Zhuochen Li | Theresa A McHugh | A. Mokdad | Simon I. Hay | Christopher J. L. Murray | George A. Mensah | Yekaterina O. Kelly | Theresa A McHugh | M.S. Shiels | Y. O. Kelly | E. Rodriquez | Parkes Kendrick
[1] S. Hay,et al. Cause-specific mortality by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities , 2023, The Lancet.
[2] G. Cholankeril,et al. Trends in mortality of liver cancer before and during the COVID‐19 pandemic, 2017–2021 , 2023, Liver international : official journal of the International Association for the Study of the Liver.
[3] Hongyu Meng,et al. Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database , 2023, Journal of gastrointestinal oncology.
[4] T. Meyer,et al. Hepatocellular carcinoma , 2022, The Lancet.
[5] M. Borad,et al. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017 , 2022, The oncologist.
[6] H. El‐Serag,et al. Neighborhood-level factors contribute to disparities in hepatocellular carcinoma incidence in Texas. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[7] Christopher J. L. Murray,et al. Life expectancy by county, race, and ethnicity in the USA, 2000–19: a systematic analysis of health disparities , 2022, The Lancet.
[8] Noele P. Nelson,et al. Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 , 2022, MMWR. Morbidity and mortality weekly report.
[9] R. Feldman,et al. Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries , 2022, PloS one.
[10] Xiaoxiao Sun,et al. Advancing Liver Cancer Prevention for American Indian Populations in Arizona: An Integrative Review , 2022, International journal of environmental research and public health.
[11] B. McMahon,et al. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992–2018 , 2022, Hepatology.
[12] Yanning Liu,et al. Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study , 2022, Cancer control : journal of the Moffitt Cancer Center.
[13] Vijay Kumar Chattu,et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 , 2021, JAMA oncology.
[14] J. Bruix,et al. BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update. , 2021, Journal of hepatology.
[15] S. J. Henley,et al. Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017 , 2021, Cancer Epidemiology, Biomarkers & Prevention.
[16] Shelly C. Lu,et al. The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States. , 2021, Journal of the National Cancer Institute.
[17] Po‐Hong Liu,et al. Comparison of Hepatocellular Carcinoma in Hispanic and Non-Hispanic Patients , 2021, Cureus.
[18] D. Goldberg,et al. County Differences in Liver Mortality in the US: Impact of Sociodemographics, Disease Risk Factors, and Access to Care. , 2020, Gastroenterology.
[19] Navid Rabiee,et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.
[20] M. Wagner,et al. New frontiers in liver resection for hepatocellular carcinoma , 2020, JHEP reports : innovation in hepatology.
[21] Yulei N. Wang,et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. , 2020, The New England journal of medicine.
[22] A. Lok,et al. Chronic Hepatitis B Prevalence Among Foreign‐Born and U.S.‐Born Adults in the United States, 1999‐2016 , 2020, Hepatology.
[23] D. Kanny,et al. Trends in Total Binge Drinks per Adult Who Reported Binge Drinking — United States, 2011–2017 , 2020, MMWR. Morbidity and mortality weekly report.
[24] Jessica L. Barrett,et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. , 2019, The New England journal of medicine.
[25] R. Bataller,et al. Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century. , 2019, The American journal of gastroenterology.
[26] A. Ejaz,et al. Intrahepatic Cholangiocarcinoma. , 2019, Surgical oncology clinics of North America.
[27] Purushottam W. Laud,et al. Racial disparities of liver cancer mortality in Wisconsin , 2019, Cancer Causes & Control.
[28] Chenchen Xie,et al. Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? , 2019, Translational gastroenterology and hepatology.
[29] O. Adegbala,et al. Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States , 2019, Annals of gastroenterology.
[30] E. Kobetz,et al. Liver cancer: A leading cause of cancer death in the United States and the role of the 1945–1965 birth cohort by ethnicity , 2019, JHEP reports.
[31] J. Marrero,et al. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[32] A. Suk-Fong Lok. Hepatitis B Treatment: What We Know Now and What Remains to Be Researched , 2018, Hepatology communications.
[33] Andrew A. Li,et al. Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016 , 2018, Journal of viral hepatitis.
[34] E. Tapper,et al. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study , 2018, British Medical Journal.
[35] Jiaquan Xu. Trends in Liver Cancer Mortality Among Adults Aged 25 and Over in the United States, 2000-2016. , 2018, NCHS data brief.
[36] T. Asselah,et al. Treatment of hepatitis C virus infection with direct‐acting antiviral agents: 100% cure? , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[37] H. Weir,et al. Liver cancer survival in the United States by race and stage (2001‐2009): Findings from the CONCORD‐2 study , 2017, Cancer.
[38] D. Goldberg,et al. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End‐Stage Liver Disease Patients , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] A. Jemal,et al. Disparities in liver cancer occurrence in the United States by race/ethnicity and state , 2017, CA: a cancer journal for clinicians.
[40] Rebecca W. Stubbs,et al. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014 , 2017, JAMA.
[41] V. Rapisarda,et al. Non-infective occupational risk factors for hepatocellular carcinoma: A review , 2016, Molecular medicine reports.
[42] Mohsen Naghavi,et al. US County-Level Trends in Mortality Rates for Major Causes of Death, 1980-2014. , 2016, JAMA.
[43] Gretchen A. Stevens,et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, The Lancet.
[44] Noele P. Nelson,et al. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. , 2016, Clinics in liver disease.
[45] R. Gish,et al. Race/ethnicity‐specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States , 2016, Cancer.
[46] B. Graubard,et al. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States , 2016, Cancer.
[47] T. Pawlik,et al. Hepatocellular carcinoma: From diagnosis to treatment. , 2016, Surgical oncology.
[48] Anders Nielsen,et al. TMB: Automatic Differentiation and Laplace Approximation , 2015, 1509.00660.
[49] D. Abbott,et al. Disparities in care for patients with curable hepatocellular carcinoma. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[50] Mei-Hwei Chang,et al. Prevention of hepatitis B. , 2015, Cold Spring Harbor perspectives in medicine.
[51] L. Nguyen,et al. Ethnic disparities and liver transplantation rates in hepatocellular carcinoma patients in the recent era: Results from the surveillance, epidemiology, and end results registry , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[52] H. Luma,et al. The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. , 2014, Journal of hepatology.
[53] S. J. Henley,et al. Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States , 2014, The American Journal of Gastroenterology.
[54] Aijaz Ahmed,et al. Both HCV and HBV are Major Causes of Liver Cancer in Southeast Asians , 2013, Journal of Immigrant and Minority Health.
[55] S. Altekruse,et al. Time Trends in Liver Cancer Mortality, Incidence, and Risk Factors by Unemployment Level and Race/Ethnicity, United States, 1969–2011 , 2013, Journal of Community Health.
[56] Andrew M. Penner,et al. Cause of Death Affects Racial Classification on Death Certificates , 2011, PloS one.
[57] J. Dimick,et al. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. , 2010, Archives of surgery.
[58] M. Naghavi,et al. Algorithms for enhancing public health utility of national causes-of-death data , 2010, Population health metrics.
[59] S. Bhatia,et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States , 2010, Cancer.
[60] G. Davis,et al. The Healthcare Burden Imposed by Liver Disease in Aging Baby Boomers , 2010, Current gastroenterology reports.
[61] M. Putt,et al. Racial/ethnic differences in physician distrust in the United States. , 2007, American journal of public health.
[62] W. Kim. Epidemiology of hepatitis B in the United States , 2007, Hepatology.
[63] Hegang Chen,et al. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. , 2006, Journal of the National Medical Association.
[64] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[65] S. Asch,et al. Surgery for Hepatocellular Carcinoma: Does It Improve Survival? , 2004, Annals of Surgical Oncology.
[66] G. Gores,et al. Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status , 2003, American Journal of Gastroenterology.
[67] H. El‐Serag,et al. Hepatocellular carcinoma. , 2011, The New England journal of medicine.
[68] H. El‐Serag,et al. Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study , 2006 .
[69] P Boffetta,et al. Socioeconomic differences in cancer incidence and mortality. , 1997, IARC scientific publications.
[70] D. Woodfield. Hepatocellular carcinoma. , 1986, The New Zealand medical journal.